内镜下动静脉瘘创建术的有效性与安全性:系统评价、Meta分析与Meta回归
该系统评价与Meta分析纳入7项研究共300例终末期肾病患者,评估经皮内镜下动静脉瘘创建术的有效性与安全性。汇总技术成功率为97.50%,90天成熟率为89.27%,6个月和12个月通畅率分别为91.99%和85.71%,总体手术相关并发症率为5.46%。结论认为内镜下动静脉瘘创建系统有效且安全,但因缺乏与手术造瘘的头对头比较,无法确立其优越性。
要点
- 内镜下动静脉瘘创建术汇总技术成功率达97.50%,90天成熟率为89.27%。
- 6个月和12个月通畅率分别为91.99%和85.71%,总体手术相关并发症率为5.46%。
- 缺乏与手术动静脉瘘创建的头对头比较,无法确立内镜 approach 的优越性。
核心结论
- 当前内镜下动静脉瘘创建系统似乎有效且安全,但因缺乏与手术创建的头对头比较分析,无法确立其优越性。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA指南,电子检索主要数据库识别相关文献。
- 共纳入7项研究总计300例患者,其中4项评估everlinQ系统,3项采用Ellipsys系统。
- 进行了比例Meta分析与Meta回归分析。
主要发现
- 总体技术成功率为97.50%(95%CI 94.98-99.31%;I2=0.00%;P=.487)。
- 90天成熟率为89.27%(95%CI 84.00-93.66%;I2=21.29%;P=.283)。
- 6个月通畅率为91.99%(95%CI 87.98-95.35%;I2=0.00%;P=.780),12个月通畅率为85.71%(95%CI 79.90-90.71%;I2=0.00%;P=NS)。
- 总体手术相关并发症率为5.46%(95%CI 0.310-14.42%;I2=81.21%;P=.000)。
- Meta回归显示年龄、糖尿病、白人种族、高血压、透析状态和体重指数均非异质性的显著来源。
临床怎么用
- 内镜下动静脉瘘创建可作为终末期肾病患者造瘘的微创选择,技术成功率和成熟率较高。
- 需注意总体手术相关并发症率约5.46%,且缺乏与手术造瘘的对比证据,临床决策应个体化。
局限性
- 缺乏与手术动静脉瘘创建的头对头比较分析,无法确立优越性。
- 纳入研究数量有限(7项,300例患者),并发症率异质性较高(I2=81.21%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The percutaneous endovascular approach to arteriovenous fistula (AVF) creation is a minimally invasive alternative to surgical AVF creation. This systematic review and meta-analysis aimed to investigate the efficacy and safety of endovascular AVF creation in patients with end-stage renal disease. METHODS: This study conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. An electronic search was performed on major databases to identify relevant articles. Meta-analysis of proportions and meta-regression were conducted. RESULTS: Seven studies totaling 300 patients were included, of which four evaluated the everlinQ (TVA Medical, Austin, Tex) and three employed the Ellipsys (Avenu Medical, San Juan Capistrano, Calif) systems. The overall technical success rate was 97.50% (95% confidence interval [CI], 94.98-99.31%; I2 = 0.00%; P = .487). The 90-day maturation rate was 89.27% (95% CI, 84.00-93.66%; I2 = 21.29%; P = .283), and the 6-month patency and 12-month patency were 91.99% (95% CI, 87.98-95.35%; I2 = 0.00%; P = .780) and 85.71% (95% CI, 79.90-90.71%; I2 = 0.00%; P = NS), respectively. The overall procedure-related complication rate was 5.46% (95% CI, 0.310-14.42%; I2 = 81.21%; P = .000). Meta-regression was conducted on the pooled rates of technical success and complication, showing that age, diabetes, white race, hypertension, on dialysis, and body mass index were not significant sources of heterogeneity. CONCLUSIONS: Current endovascular AVF systems appear to be effective and safe. However, given the lack of head-to-head comparative analyses with surgical AVF creation, superiority cannot be established.
引用
- Yan Wee IJ, Yap HY, Tang TY, et al. A systematic review, meta-analysis, and meta-regression of the efficacy and safety of endovascular arteriovenous fistula creation. J Vasc Surg. 2019. PMID: 31564584. doi:10.1016/j.jvs.2019.07.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。